Key result
Stentless aortic xenografts provide more physiologic hemodynamics and may improve long-term survival compared to stented bioprostheses, though expected durability advantages have not been fulfilled.
Why the study?
Do stentless aortic xenografts improve hemodynamics, durability, and survival compared to stented bioprostheses in patients requiring aortic valve replacement?
Do stentless aortic xenografts improve hemodynamics, durability, and survival compared to stented bioprostheses in patients requiring aortic valve replacement?
Stentless aortic valves offer excellent hemodynamics and versatility in complex aortic root pathology, though their durability advantage over modern stented valves remains unproven.
Answers are grounded in this paper and cite their sources.
Supports use in complex root pathology; leaves open whether durability or survival advantages hold versus modern stented valves.
Stentless aortic xenografts were introduced into clinical practice as aortic valve substitutes over a decade ago. Stentless prosthetic valves were expected to provide enhanced durability and more physiologic hemodynamic behavior when compared with stented bioprostheses. Whilst the former expectation has not been fulfilled, partly due to concomitantly improved durability of second-generation stented bioprostheses, the latter has consistently been satisfied in early and late clinical observation. Evidence is accumulating suggesting improved long-term survival due to more timely and thorough regression of ventricular hypertrophy. In addition, stentless xenografts have shown extreme versatility when adopted in a variety of complex clinical conditions associated with aortic valve disease, including small aortic anulus, ascending aortic aneurysm, endocarditis and left ventricular dysfunction. Future research in the form of prospective, multicenter, randomized trials must address the issues of very long-term durability and survival, while simplification in valve design is required to promote wider use of stentless valves.
No takes yet. Share an insight, caveat, or question.
Giovanni Battista Luciani (2004) conducted a review in Aortic valve disease. Stentless aortic xenografts vs. Stented bioprostheses was evaluated. Stentless aortic xenografts provide more physiologic hemodynamics and may improve long-term survival compared to stented bioprostheses, though expected durability advantages have not been fulfilled.
Synapse has enriched 10 related papers. Consider them for comparative context: